Kineta Announces Completion of Enrollment in the Monotherapy Arm of the VISTA-101 Phase 1 Clinical Study in Advanced Solid Tumors
ImmunotherapyClinical ResultAACR
ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program
Vaccine
Kronos Bio Announces Selection of Autoimmune Development Candidate for Sjögren’s Disease
Clinical Result
Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate Updates
Clinical ResultADC
Ultragenyx Receives Breakthrough Therapy Designation for Setrusumab (UX143) in Osteogenesis Imperfecta
Clinical ResultLicense out/inOrphan DrugBreakthrough Therapy
OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million
AcquisitionExecutive Change
PulseSight Therapeutics to Present Data on PST-611 at EVER Congress 2024
INDGene Therapy
Avillion announces positive high-level results from Phase III BATURA trial with AstraZeneca’s inhaled anti-inflammatory medication Airsupra in asthma patients
Clinical ResultDrug Approval
Clinical ResultASCO
ImmunotherapyClinical Study